View this article online at www.insightplus.mja.com.au
“It is not death that a man should fear, rather he should fear never beginning to live” - Marcus Aurelius
Rising temperatures could increase the burden of mental and behavioural disorders by nearly 50% by 2050, challenging Australia’s health care system.
Monoclonal antibody therapies for severe asthma can reduce risky corticosteroid loads, but are still underutilised, writes clinical associate professor Debbie Rigby.
A recent outbreak of polio in Papua New Guinea raises concerns about the potential spread to neighbouring countries, including Australia.
The effectiveness of current workforce targets to improve the quality of aged care remains unclear
A new screening tool, The General Practice Sleep Scale, holds promise as a practical, real-world solution to obstructive sleep apnoea underdiagnosis in general practice.
The New South Wales government this week announced reforms that will allow some GPs to treat and potentially diagnose attention-deficit hyperactivity disorder (ADHD).
Research suggests that persuasive and misleading communication practices are widely used by tobacco and vape industry actors to undermine the development of public policy that threatens their profits.
This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.
